REQUEST A DEMO
Total
USD $0.00
Search more companies

Soluciones Medicas del Oriente S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Soluciones Medicas del Oriente S.A.S. Profile Updated: April 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Soluciones Medicas del Oriente S.A.S. is an enterprise in Colombia, with the main office in Bucaramanga. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Soluciones Medicas del Oriente S.A.S. was incorporated on December 19, 2016. The company’s latest financial report indicates a net sales revenue drop of 1.11% in 2023. There was a total growth of 10.62% in Soluciones Medicas del Oriente S.A.S.’s total assets over the same period. In 2023, Soluciones Medicas del Oriente S.A.S.’s net profit margin increased by 10.25%.

Headquarters
Carrera 20 # 158 - 40 Barrio Canaveral
Bucaramanga; Santander;

Contact Details: Purchase the Soluciones Medicas del Oriente S.A.S. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Soluciones Medicas del Oriente S.A.S. report to view the information.
Incorporation Date:
December 19, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Soluciones Medicas del Oriente S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-1.11%
Total operating revenue
-1.11%
Net Profit (Loss) for the Period
16.23%
Total assets
10.62%
Total equity
13.08%
Net Profit Margin
10.25%
Return on Equity (ROE)
2.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?